We are live on ! Find out more
RXST icon

RxSight

214 hedge funds and large institutions have $1.68B invested in RxSight in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 65 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,355% more call options, than puts

Call options by funds: $23.1M | Put options by funds: $1.59M

37% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 65

1.01% more ownership

Funds ownership: 84.53%85.54% (+1%)

6% less funds holding

Funds holding: 228214 (-14)

15% less capital invested

Capital invested by funds: $1.98B → $1.68B (-$305M)

29% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 45

71% less funds holding in top 10

Funds holding in top 10: 72 (-5)

Holders
214
Holders Change
-14
Holders Change %
-6.14%
% of All Funds
3.07%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.03%
New
32
Increased
89
Reduced
65
Closed
45
Calls
$23.1M
Puts
$1.59M
Net Calls
+$21.6M
Net Calls Change
+$18.1M

RXST Hedge Fund Activity: Q3 2024 in Review

214 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q3 2024, worth a combined $1.68B — down 15% from $1.98B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of RXST and 32 opened new positions — a net loss of 13 holders — while 65 trimmed existing stakes and 89 added.

The largest buyer was Bank of America, adding an estimated $50.8M. The largest seller was Lord, Abbett & Co, cutting an estimated $35.1M.

  • 214 institutional investors held RxSight (RXST) as of Q3 2024, down from 228 in Q2 2024.
  • Funds reported $1.68B of RxSight stock for Q3 2024, down 15% quarter-over-quarter.
  • 32 funds opened new RxSight positions in Q3 2024 and 45 closed out, a net change of -13 holders.
  • The largest RxSight buyer in Q3 2024 was Bank of America, an estimated $50.8M added.
  • The largest RxSight seller in Q3 2024 was Lord, Abbett & Co, an estimated $35.1M sold.

Based on aggregated 13F filings for Q3 2024.